October 15, 2009: 12:41 pm:
FDA approves Sirion’s Zirgan for treating acute herpetic keratitis (News-Medical-Net)
What’s new in the lasik industry? It seems as though there’s always far more than what I have time to write about…
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Read full story
